Last 7 days
0.2%
Last 30 days
1.2%
Last 90 days
54.1%
Trailing 12 Months
14.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
BSX | 69.1B | 12.7B | 0.59% | 12.45% | 99.06 | 5.45 | 6.68% | -32.95% |
BDX | 67.4B | 19.0B | -5.16% | -6.78% | 41.86 | 3.55 | -0.43% | -8.78% |
EW | 49.8B | 5.4B | 2.41% | -25.12% | 32.74 | 9.26 | 2.86% | 1.25% |
MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 9.34% | 31.15% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
TNDM | 2.7B | 801.2M | 1.13% | -58.87% | -28.25 | 3.34 | 14.00% | -707.69% |
SMALL-CAP | ||||||||
SILK | 1.7B | 138.6M | -15.68% | 29.18% | -30.43 | 12.07 | 36.62% | -10.44% |
ATEC | 1.6B | 350.9M | 10.38% | 49.06% | -10.84 | 4.7 | 44.26% | -5.42% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
CSII | 828.4M | 239.8M | 0.30% | 1.49% | -21.88 | 3.45 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Revenue | 1.7% | 1,074 | 1,056 | 1,032 | 1,003 | 974 |
S&GA Expenses | 3.2% | 452 | 438 | 423 | 414 | 393 |
R&D Expenses | 0.6% | 167 | 166 | 163 | 152 | 144 |
Costs and Expenses | 2.5% | 820 | 800 | 891 | 865 | 828 |
EBITDA | 23.9% | 369 | 298 | 219 | 217 | - |
EBITDA Margin | 21.9% | 0.34* | 0.28* | 0.21* | 0.22* | - |
Earnings Before Taxes | 26.5% | 341 | 270 | 191 | 189 | 212 |
EBT Margin | 24.4% | 0.32* | 0.26* | 0.18* | 0.19* | - |
Net Income | 22.6% | 267 | 218 | 137 | 133 | 149 |
Net Income Margin | 20.6% | 0.25* | 0.21* | 0.13* | 0.13* | - |
Free Cahsflow | -17.3% | 217 | 263 | 250 | 246 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Assets | -0.4% | 1,697 | 1,704 | 1,673 | 1,593 | 1,530 |
Current Assets | 0.2% | 1,063 | 1,060 | 976 | 885 | 871 |
Cash Equivalents | 1.0% | 182 | 180 | 133 | 144 | 242 |
Inventory | 7.2% | 102 | 95.00 | 94.00 | 90.00 | 86.00 |
Net PPE | -1.7% | 195 | 198 | 202 | 197 | 197 |
Goodwill | -2.5% | 73.00 | 75.00 | 77.00 | 77.00 | 78.00 |
Liabilities | -6.4% | 157 | 167 | 170 | 160 | 145 |
Current Liabilities | -4.8% | 134 | 141 | 138 | 127 | 114 |
Shareholder's Equity | 0.2% | 1,540 | 1,536 | 1,503 | 1,433 | 1,385 |
Retained Earnings | 10.4% | 1,125 | 1,019 | 965 | 904 | 858 |
Additional Paid-In Capital | 2.2% | 905 | 885 | 870 | 853 | 840 |
Accumulated Depreciation | 3.9% | 106 | 102 | 99.00 | 93.00 | - |
Shares Outstanding | -0.9% | 45.00 | 46.00 | 46.00 | 46.00 | 45.00 |
Float | - | 14,400 | - | - | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Cashflow From Operations | -15.8% | 251 | 298 | 285 | 293 | 282 |
Share Based Compensation | 0.5% | 54.00 | 53.00 | 53.00 | 54.00 | 55.00 |
Cashflow From Investing | 38.2% | -162 | -263 | -380 | -324 | -250 |
Cashflow From Financing | -626.0% | -135 | -18.67 | -2.20 | -1.58 | 6.00 |
Buy Backs | 772.2% | 253 | 29.00 | 0.00 | - | - |
80%
58.1%
31.5%
Y-axis is the maximum loss one would have experienced if Abiomed was unfortunately bought at previous high price.
39.5%
23.2%
14.7%
32.7%
FIve years rolling returns for Abiomed.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | sold off | -100 | -217,000 | - | -% |
2023-03-10 | BAILLIE GIFFORD & CO | reduced | -99.92 | -889,365,000 | 1,136,580 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | sold off | -100 | -1,981,000 | - | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -98.99 | -22,791,000 | 361,000 | -% |
2023-03-03 | TIAA, FSB | sold off | -100 | -250,000 | - | -% |
2023-03-01 | WHITENER CAPITAL MANAGEMENT, INC. | sold off | -100 | -415,000 | - | -% |
2023-02-28 | Voya Investment Management LLC | sold off | -100 | -6,959,000 | - | -% |
2023-02-24 | National Pension Service | sold off | -100 | -19,252,300 | - | -% |
2023-02-24 | NATIXIS | sold off | -100 | -2,940,000 | - | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -89.99 | -8,166,000 | 1,501,000 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jan 06, 2023 | baillie gifford & co | 0.01% | 2,991 | SC 13G/A | |
Dec 29, 2022 | millennium management llc | 0.0% | 0 | SC 13G | |
Feb 09, 2022 | vanguard group inc | 10.64% | 4,842,984 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 5.41% | 2,461,221 | SC 13G | |
Jan 18, 2022 | baillie gifford & co | 8.44% | 3,839,980 | SC 13G/A | |
Jan 10, 2022 | blackrock inc. | 10.1% | 4,592,566 | SC 13G/A | |
Feb 16, 2021 | sands capital management, llc | 3.27% | 1,479,909 | SC 13G | |
Feb 10, 2021 | vanguard group inc | 10.63% | 4,801,759 | SC 13G/A | |
Feb 10, 2021 | renaissance technologies llc | 4.41% | 1,993,800 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 9.1% | 4,127,359 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 80.22 - | 99.36 - | 131.90 - | 255.51 - | 350.32 - |
Current Inflation | 74.18 - | 90.52 - | 117.84 - | 223.06 - | 303.31 - |
Very High Inflation | 66.71 - | 79.82 - | 101.20 - | 185.39 - | 249.11 - |
Date Filed | Form Type | Document | |
---|---|---|---|
Jan 06, 2023 | SC 13G/A | Major Ownership Report | |
Jan 03, 2023 | 15-12G | 15-12G | |
Dec 29, 2022 | SC 13G | Major Ownership Report | |
Dec 27, 2022 | 4 | Insider Trading | |
Dec 27, 2022 | 4 | Insider Trading | |
Dec 27, 2022 | 4 | Insider Trading | |
Dec 27, 2022 | 4 | Insider Trading | |
Dec 27, 2022 | 4 | Insider Trading | |
Dec 27, 2022 | 4 | Insider Trading | |
Dec 27, 2022 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2022-02-17 | Rolle Myron L | sold (taxes) | -36,447 | 325 | -112 | - |
2022-02-17 | SUTTER MARTIN P | sold | -1,258,850 | 314 | -4,000 | - |
2022-02-16 | SUTTER MARTIN P | sold | -617,322 | 308 | -2,000 | - |
2022-02-16 | Weber David M | sold | -2,437,500 | 325 | -7,500 | chief operating officer |
2022-02-15 | SUTTER MARTIN P | sold | -607,301 | 303 | -2,000 | - |
2022-02-09 | Weber David M | sold | -965,311 | 310 | -3,112 | chief operating officer |
2022-02-09 | Weber David M | acquired | 67,063 | 21.55 | 3,112 | chief operating officer |
2022-02-08 | Weber David M | acquired | 159,750 | 21.55 | 7,413 | chief operating officer |
2022-02-08 | Weber David M | sold | -2,245,420 | 302 | -7,413 | chief operating officer |
2022-02-07 | Weber David M | acquired | 6,465 | 21.55 | 300 | chief operating officer |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Revenue | $ 265,921 | $ 248,142 | $ 543,070 | $ 500,727 |
Costs and expenses: | ||||
Cost of revenue | 48,880 | 43,886 | 101,506 | 89,074 |
Research and development | 42,089 | 41,041 | 82,566 | 78,749 |
Selling, general and administrative | 116,958 | 102,779 | 234,954 | 206,263 |
Acquired in-process research and development | 0 | 0 | 0 | 115,490 |
Costs and Expenses, Total | 207,927 | 187,706 | 419,026 | 489,576 |
Other (loss) income: | ||||
Income from operations | 57,994 | 60,436 | 124,044 | 11,151 |
Interest and other income, net | 80,709 | 6,835 | 84,481 | 46,770 |
Income before income taxes | 138,703 | 67,271 | 208,525 | 57,921 |
Income tax provision | 32,570 | 10,318 | 47,838 | 27,493 |
Net income | $ 106,133 | $ 56,953 | $ 160,687 | $ 30,428 |
Net income per share - basic | $ 2.34 | $ 1.25 | $ 3.53 | $ 0.67 |
Weighted average shares outstanding - basic | 45,372 | 45,437 | 45,475 | 45,374 |
Net income per share - diluted | $ 2.32 | $ 1.24 | $ 3.51 | $ 0.66 |
Weighted average shares outstanding - diluted | 45,711 | 45,893 | 45,812 | 45,857 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2022 | Mar. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 182,335 | $ 132,818 |
Short-term marketable securities | 638,037 | 625,789 |
Accounts receivable, net | 94,475 | 90,608 |
Inventories, net | 102,237 | 93,981 |
Prepaid expenses and other current assets | 45,714 | 33,277 |
Total current assets | 1,062,798 | 976,473 |
Long-term marketable securities | 116,871 | 220,089 |
Property and equipment, net | 195,157 | 202,490 |
Goodwill | 72,960 | 76,786 |
Other intangibles, net | 36,833 | 39,518 |
Deferred tax assets | 18,881 | 10,552 |
Other assets | 193,044 | 147,485 |
Total assets | 1,696,544 | 1,673,393 |
Current liabilities: | ||
Accounts payable | 35,070 | 35,346 |
Accrued expenses | 69,434 | 72,629 |
Deferred revenue | 25,962 | 26,362 |
Other current liabilities | 3,594 | 4,120 |
Total current liabilities | 134,060 | 138,457 |
Other long-term liabilities | 7,013 | 9,319 |
Contingent consideration | 14,995 | 21,510 |
Deferred tax liabilities | 689 | 781 |
Total liabilities | 156,757 | 170,067 |
Commitments and contingencies (Note 16) | ||
Stockholders' equity: | ||
Class B Preferred Stock, $.01 par value Authorized - 1,000,000 shares; Issued and outstanding - none | ||
Common stock, $.01 par value 100,000 shares authorized; 48,418 and 48,258 shares issued as of September 31, 2022 and March 31, 2022, respectively 45,172 and 45,545 shares outstanding as of September 30, 2022 and March 31, 2022, respectively | 452 | 455 |
Additional paid in capital | 904,755 | 870,074 |
Retained earnings | 1,125,199 | 964,512 |
Treasury stock at cost - 3,246 and 2,713 shares as of September 31, 2022 and March 31, 2022, respectively | (443,974) | (304,555) |
Accumulated other comprehensive loss | (46,645) | (27,160) |
Total stockholders' equity | 1,539,787 | 1,503,326 |
Total liabilities and stockholders' equity | $ 1,696,544 | $ 1,673,393 |